Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Letrozole Combined With Anlotinib Hydrochloride in the Treatment of Platinum-resistant Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating letrozole combined with anlotinib hydrochloride for platinum-resistant recurrent ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy
Clinical trial evaluating whether fallopian tube cells collected by Cytuity can determine the presence of malignancy compared with removed o…
-
CLINICAL_TRIALS trial_result · 2020-12-28Clinical Trial Update: Efficacy Study of CPC634 (CriPec® Docetaxel) in Platinum Resistant Ovarian Cancer [Phase 2]
Phase 2 trial update for CPC634 (CriPec Docetaxel) in platinum-resistant ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating enzastaurin for persistent or recurrent ovarian or primary peritoneal cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer [Phase 3]
A Phase 3 trial comparing patupilone to doxorubicin in ovarian, fallopian tube, or peritoneal cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 3]
This Phase 3 trial evaluates whether adding bevacizumab to a carboplatin, paclitaxel, and gemcitabine regimen after surgery improves outcome…
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer. [Phase 2]
Phase 2 trial update on paclitaxel-albumin bound with carboplatin for ovarian cancer report focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients [Phase 2, Phase 3]
Phase 2/3 trial update for masitinib in combination with gemcitabine in advanced/metastatic epithelial ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II) [Phase 1, Phase 2]
Phase I/II study of oral rucaparib in patients with BRCA-mutant ovarian cancer and to a lesser extent solid tumors; study completed with res…
-
CLINICAL_TRIALS trial_result · 2020-11-30Clinical Trial Update: Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer [Phase 2]
Phase 2 trial assessing tocotrienol as a nutritional supplement in patients with advanced ovarian cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating dual therapy with Anlotinib and Niraparib for platinum-resistant recurrent ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-18Clinical Trial Update: Combination Chemotherapy With CS-1008 to Treat Ovarian Cancer [Phase 2]
Phase 2 trial update of CS-1008 in combination chemotherapy for ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian Cancer [Phase 1]
Phase Ib/II study of carboplatin plus M6620 and avelumab in PARP inhibitor-resistant ovarian cancer has completed phase 1 with results poste…
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating anlotinib in combination with dose-reduced olaparib for platinum-sensitive recurrent ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial evaluating apatinib in combination with Abraxane and carboplatin or cisplatin as first-line therapy for epithelial ovarian can…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill") [Phase 2]
Phase 2 trial comparing standard chemotherapy plus enzastaurin versus placebo in ovarian cancer; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand [Phase 2]
Phase 2 trial update on intraoperative detection of occult ovarian cancer using a folate-receptor targeted fluorescent ligand; study termina…
-
CLINICAL_TRIALS research · 2020-10-14Clinical Trial Update: Surgical Complications Related to Primary or Interval Debulking in Ovarian Neoplasm [Phase 3]
A Phase 3 clinical trial update evaluating surgical complications related to primary or interval debulking in ovarian neoplasm.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel [Phase 3]
Phase 3 trial evaluating cetirizine as a replacement for diphenhydramine to prevent reactions related to paclitaxel in cancer patients; stud…
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: Cabazitaxel in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy. [Phase 2]
A Phase 2 clinical trial assessing cabazitaxel in patients with recurrent ovarian cancer after failure of standard therapy has completed.
-
CLINICAL_TRIALS trial_result · 2020-09-28Clinical Trial Update: A Phase II Study of Neoadjuvant Chemotherapy Plus Durvalumab (MEDI4736) and Tremelimumab in Advanced-stage Ovarian Cancer (TRU-D) [Phase 2]
Phase II study evaluating neoadjuvant chemotherapy combined with durvalumab and tremelimumab in advanced-stage ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer [Phase 2]
Phase 2 trial evaluating the effectiveness of oregovomab plus chemotherapy in advanced ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
A Phase 3 trial evaluating veliparib with carboplatin/paclitaxel and continuation maintenance in newly diagnosed stage III/IV high-grade ser…
-
CLINICAL_TRIALS trial_result · 2020-09-11Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial update reporting results for nivolumab with or without ipilimumab in patients with persistent or recurrent ovarian, fallopian …
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation [Phase 3]
Phase 3 randomized trial investigating HIPEC in recurrent ovarian cancer patients with HRR gene mutations; status not yet determined.